Literature DB >> 6391765

Solubilization of immune complex deposits by native 7S IgG molecules in lupus glomerulonephritis--a possible antigen excess effect on rheumatoid factor-IgG complexes.

Y Suzuki, T Oite, F Shimizu, K Yamamoto, S Suzuki, M Arakawa.   

Abstract

IgM and IgG class rheumatoid factor (RF) containing glomerular immune complex (IC) deposits were detected in renal biopsy material from 10 out of 123 patients with various forms of glomerulonephritis (GN) by an immunofluorescent assay using FITC conjugated aggregated human IgG(FAHIgG). In lupus GN, six out of 28 cases (23.5%), showed such activity. Solubilization of glomerular IC deposits in frozen sections of lupus GN was observed after a 5 h incubation with native 7S IgG. The binding of FAHIgG to glomerular IC deposits and solubilization of deposits by excess HIgG were also confirmed in sections of two types of rat experimental GN in which HIgG acted as exogenous antigen; in situ IC formation type GN in cationized HIgG planted kidneys and chronic serum sickness type GN. These results suggest a possible antigen excess mechanism contributing to the solubilization of glomerular IC deposits via RF and IgG interactions in lupus GN.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6391765      PMCID: PMC1577093     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  22 in total

1.  The hydrolysis of rabbit y-globulin and antibodies with crystalline papain.

Authors:  R R PORTER
Journal:  Biochem J       Date:  1959-09       Impact factor: 3.857

2.  A new complement function: solubilization of antigen-antibody aggregates.

Authors:  G W Miller; V Nussenzweig
Journal:  Proc Natl Acad Sci U S A       Date:  1975-02       Impact factor: 11.205

3.  Delayed removal of renal-bound antigen in decomplemented rabbits with acute serum sickness.

Authors:  S R Bartolotti; D K Peters
Journal:  Clin Exp Immunol       Date:  1978-05       Impact factor: 4.330

Review 4.  Immune complex systems in the nephritis of systemic lupus erythematosus.

Authors:  V Agnello; D Koffler; H G Kunkel
Journal:  Kidney Int       Date:  1973-02       Impact factor: 10.612

5.  The effect of antigen excess on chronic immune complex glomerulonephritis.

Authors:  A J Valdes; L B Senterfit; A D Pollack; F G Germuth
Journal:  Johns Hopkins Med J       Date:  1969-01

6.  Removal of glomerular deposits of immune complexes in mice by administration of excess antigen.

Authors:  M Mannik; G E Striker
Journal:  Lab Invest       Date:  1980-05       Impact factor: 5.662

7.  Antiglobulins and glomerulonephritis. Classification of patients by the reactivity of their sera and renal tissue with aggregated and native human IgG.

Authors:  R D Rossen; M A Reisberg; J T Sharp; W N Sucki; F X Schloeder; L L Hill; G Eknoyan
Journal:  J Clin Invest       Date:  1975-08       Impact factor: 14.808

8.  Renal localization of antiglobulins in glomerulonephritis and after renal transplantation.

Authors:  R D Rossen; R H Rickaway; M A Reisberg; D B Singer; F X Schloeder; W N Suki; L L Hill; G Eknoyan
Journal:  Arthritis Rheum       Date:  1977-05

9.  The glomerular mesangium. I. Kinetic studies of macromolecular uptake in normal and nephrotic rats.

Authors:  S M Mauer; A J Fish; E B Blau; A F Michael
Journal:  J Clin Invest       Date:  1972-05       Impact factor: 14.808

10.  Evidence of an autologous immune complex pathogenic mechanism in acute poststreptococcal glomerulonephritis.

Authors:  R M McIntosh; R García; L Rubio; D Rabideau; J E Allen; R I Carr; B Rodríguez-Iturbe
Journal:  Kidney Int       Date:  1978-11       Impact factor: 10.612

View more
  2 in total

1.  Hypothesis: selective ineffective humoral immune responsiveness as a possible cause of certain chronic inflammatory disorders. Theoretical considerations and rationale for treatment.

Authors:  A Hässig; H Cottier
Journal:  Klin Wochenschr       Date:  1986-05-02

2.  Complement-activating properties of immune complexes are suppressed by IgM rheumatoid factor and enhanced by IgG rheumatoid factor.

Authors:  M Shingu; I Ezaki; M Nobunaga
Journal:  Rheumatol Int       Date:  1988       Impact factor: 2.631

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.